Citadel Advisors’s JPMorgan Healthcare Leaders ETF JDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$449K Sell
7,460
-12,961
-63% -$731K ﹤0.01% 10128
2026
Q1
$1.13M Buy
20,421
+11,856
+138% +$685K ﹤0.01% 7379
2025
Q4
$495K Buy
+8,565
New +$483K ﹤0.01% 9040
2024
Q2
Sell
-34,914
Closed -$2.04M 14867
2024
Q1
$2.04M Sell
34,914
-34,958
-50% -$1.97M ﹤0.01% 5475
2023
Q4
$3.76M Buy
+69,872
New +$3.57M ﹤0.01% 4246

Other funds holding JDOC

Citadel Advisors's JDOC Position: Q2 2026 in Review

Citadel Advisors reduced its JPMorgan Healthcare Leaders ETF (JDOC) stake by 63% in Q2 2026, selling an estimated $731K and leaving 7,460 shares worth $449K. The position accounts for ﹤0.01% of the portfolio, ranked #10128.

Citadel Advisors first reported a position in JDOC in Q4 2023 and has held it in 5 quarters since. The position peaked at $3.76M in Q4 2023. 6 funds tracked by Wall St. Rank hold JDOC as of Q2 2026.

  • Citadel Advisors held 7,460 shares of JPMorgan Healthcare Leaders ETF worth $449K as of Q2 2026.
  • Citadel Advisors sold 12,961 JPMorgan Healthcare Leaders ETF shares in Q2 2026, an estimated $731K.
  • JPMorgan Healthcare Leaders ETF made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #10128 holding.
  • Citadel Advisors first reported a position in JPMorgan Healthcare Leaders ETF in Q4 2023 and has held it in 5 quarters since.
  • Citadel Advisors's JPMorgan Healthcare Leaders ETF position peaked at $3.76M in Q4 2023.
  • 6 funds tracked by Wall St. Rank held JPMorgan Healthcare Leaders ETF as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.